Genzyme Sues Impax Over Generic Renvela Powder
Genzyme Corp. has sued Impax Laboratories Inc. in an effort to block a generic version of kidney disease treatment Renvela in powder form, following up on earlier litigation over the tablet...To view the full article, register now.
Already a subscriber? Click here to view full article